{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:18:53Z","timestamp":1792149533483,"version":"4.4.0"},"reference-count":44,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Graves\u2019 orbitopathy (GO) is subject to epidemiological and care-related changes. Aim of the survey was to identify trends in presentation of GO to the European Group On Graves\u2019 Orbitopathy (EUGOGO) tertiary referral centres and initial management over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective observational multicentre study. All new referrals with diagnosis of GO within September\u2013December 2019 were included. Clinical and demographic characteristics, referral timelines and initial therapeutic decisions were recorded. Data were compared with a similar EUGOGO survey performed in 2012.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Besides age (mean age: 50.5\u00b113 years vs 47.7\u00b114 years; p 0.007), demographic characteristics of 432 patients studied in 2019 were similar to those in 2012. In 2019, there was a decrease of severe cases (9.8% vs 14.9; p&lt;0.001), but no significant change in proportion of active cases (41.3% vs 36.6%; p 0.217). After first diagnosis of GO, median referral time to an EUGOGO tertiary centre was shorter (2 (0\u2013350) vs 6 (0\u2013552) months; p&lt;0.001) in 2019. At the time of first visit, more patients were already on antithyroid medications (80.2% vs 45.0%; p&lt;0.001) or selenium (22.3% vs 3.0%; p&lt;0.001). In 2019, the initial management plans for GO were similar to 2012, except for lid surgery (2.4% vs 13.9%; p&lt;0.001) and prescription of selenium (28.5% vs 21.0%; p 0.027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GO patients are referred to tertiary EUGOGO centres in a less severe stage of the disease than before. We speculate that this might be linked to a broader awareness of the disease and faster and adequate delivered treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2022-322442","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T13:21:25Z","timestamp":1673356885000},"page":"294-300","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Presentation of Graves\u2019 orbitopathy within European Group On Graves\u2019 Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-8753","authenticated-orcid":false,"given":"Anna","family":"Schuh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goksun","family":"Ayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelio","family":"Baldeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-8407","authenticated-orcid":false,"given":"Maja","family":"Bareti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Heiberg","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Burlacu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Ciric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Covelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6802-0126","authenticated-orcid":false,"given":"Nicola","family":"Curr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6920-7021","authenticated-orcid":false,"given":"Simone","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja K","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jab\u0142o\u0144ska-Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Juri Mandi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Konuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Langbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lanzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Mi\u015bkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1687-9297","authenticated-orcid":false,"given":"Biljana Nedeljkovic","family":"Beleslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"P\u00e9rez-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-8751","authenticated-orcid":false,"given":"Marta","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina A","family":"Ponto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Rudofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Schittkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusun","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijay","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R","family":"Hintschich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"2024012903300918000_108.2.294.1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol"},{"key":"2024012903300918000_108.2.294.2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0548"},{"key":"2024012903300918000_108.2.294.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1275"},{"key":"2024012903300918000_108.2.294.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3873"},{"key":"2024012903300918000_108.2.294.5","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1210\/clinem\/dgab035","article-title":"Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy","volume":"106","author":"Rotondo Dottore","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012903300918000_108.2.294.6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14002"},{"key":"2024012903300918000_108.2.294.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves' disease: epidemiology, genetic and environmental risk factors and viruses","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2024012903300918000_108.2.294.8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.20452\/pamw.3592","article-title":"Cigarette smoking: number one enemy for Graves ophthalmopathy","volume":"126","author":"Bartalena","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"2024012903300918000_108.2.294.9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12222"},{"key":"2024012903300918000_108.2.294.10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390170124027"},{"key":"2024012903300918000_108.2.294.11","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476"},{"key":"2024012903300918000_108.2.294.12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eprac.2020.11.011","article-title":"Risk factors of thyroid eye disease","volume":"27","author":"Lee","year":"2021","journal-title":"Endocr Pract"},{"key":"2024012903300918000_108.2.294.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199206253262603"},{"key":"2024012903300918000_108.2.294.14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s40618-016-0484-y","article-title":"Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis","volume":"39","author":"Li","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"2024012903300918000_108.2.294.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2470"},{"key":"2024012903300918000_108.2.294.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2813"},{"key":"2024012903300918000_108.2.294.17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/biof.5520190308","article-title":"Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications","volume":"19","author":"Bartalena","year":"2003","journal-title":"Biofactors"},{"key":"2024012903300918000_108.2.294.18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000509615","article-title":"Oxidative stress in Graves disease and Graves orbitopathy","volume":"9","author":"Lanzolla","year":"2020","journal-title":"Eur Thyroid J"},{"key":"2024012903300918000_108.2.294.19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121871","article-title":"The role of oxidative stress and therapeutic potential of antioxidants in Graves' ophthalmopathy","volume":"9","author":"Hou","year":"2021","journal-title":"Biomedicines"},{"key":"2024012903300918000_108.2.294.20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves' orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"2024012903300918000_108.2.294.21","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2024012903300918000_108.2.294.22","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480491"},{"key":"2024012903300918000_108.2.294.23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306733"},{"key":"2024012903300918000_108.2.294.24","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.423"},{"key":"2024012903300918000_108.2.294.25","first-page":"182","article-title":"Epidemiology of Graves' orbitopathy","volume":"7","author":"Putta-Manohar","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"2024012903300918000_108.2.294.26","unstructured":"EUGOGO follow-up assessment proforma (in English). Available: https:\/\/www.eugogo.eu\/media\/eejpvtua\/eugogo-follow-up-assessment-proforma.pdf [Accessed 7 Jan 2022]."},{"key":"2024012903300918000_108.2.294.27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02230"},{"key":"2024012903300918000_108.2.294.28","unstructured":"Clinical evaluation atlas & ETA\/EUGOGO guidelines. (In Engish). Available: https:\/\/www.eugogo.eu\/en\/what-do-we-offer\/downloads\/ [Accessed 7 Jan 2022]."},{"key":"2024012903300918000_108.2.294.29","unstructured":"EUGOGO teaching courses and activities. (In English). Available: https:\/\/www.eugogo.eu\/en\/what-do-we-offer\/courses-and-activities\/ [Accessed 7 Jan 2022]."},{"key":"2024012903300918000_108.2.294.30","unstructured":"IBM Corp . Released 2017. IBM SPSS statistics for windows, version 25.0. Armonk, NY: IBM Corp."},{"key":"2024012903300918000_108.2.294.31","unstructured":"Europ\u00e4ische Union & Euro-Zone: Durchschnittsalter der Bev\u00f6lkerung von 2010 bis 2020. (In German). Available: https:\/\/de.statista.com\/statistik\/daten\/studie\/361632\/umfrage\/durchschnittsalter-der-bevoelkerung-in-eu-und-euro-zone\/ [Accessed 7 Jan 2022]."},{"key":"2024012903300918000_108.2.294.32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220935"},{"key":"2024012903300918000_108.2.294.33","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4676289","article-title":"Cigarette smoke extract-induced oxidative stress and fibrosis-related genes expression in orbital fibroblasts from patients with Graves' ophthalmopathy","volume":"2016","author":"Kau","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"2024012903300918000_108.2.294.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012985"},{"key":"2024012903300918000_108.2.294.35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2016.0222","article-title":"Antithyroid dugs-the most common treatment for Graves' disease in the United States: a nationwide population-based study","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"key":"2024012903300918000_108.2.294.36","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12688"},{"key":"2024012903300918000_108.2.294.37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40618-020-01320-7","article-title":"Antithyroid drugs in Graves' hyperthyroidism: differences between \"block and replace\" and \"titration\" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment","volume":"44","author":"\u017darkovi\u0107","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2024012903300918000_108.2.294.38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2024012903300918000_108.2.294.39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-017-0608-z","article-title":"Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?","volume":"40","author":"Bartalena","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2024012903300918000_108.2.294.40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024012903300918000_108.2.294.41","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0097-2"},{"key":"2024012903300918000_108.2.294.42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/eye.2008.155","article-title":"Graves' orbitopathy: frequency of ocular hypertension and glaucoma","volume":"23","author":"da Silva","year":"2009","journal-title":"Eye"},{"key":"2024012903300918000_108.2.294.43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/IJG.0000000000000942","article-title":"Prevalence of ocular hypertension and glaucoma as well as associated factors in Graves' orbitopathy","volume":"27","author":"Kim","year":"2018","journal-title":"J Glaucoma"},{"key":"2024012903300918000_108.2.294.44","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313578"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2022-322442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T19:15:12Z","timestamp":1728674112000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2022-322442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bjo-2022-322442"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2022-322442","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}